Spotlight Therapeutics
Spotlight Therapeutics is an in vivo Gene Editing founded in 2017 by Patrick Hsu, Alexander Marson and Jacob Corn.
3
Funding Rounds
$117.5m
Money raised
Overview
Spotlight Therapeutics is an in vivo Gene Editing founded in 2017 by Patrick Hsu, Alexander Marson and Jacob Corn.
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa***** Hs* | - | - | - |
| Al******* Ma**** | - | - | - |
| Ja*** Co** | - | - | - |
Funding series
Funding Series Analysis
The company Spotlight Therapeutics has raised a total of $101.5m in funding over 3 rounds.
Key Insights:
- Spotlight Therapeutics Series B round, March 2022: $36.5m
- Spotlight Therapeutics Funding Round, January 2022: $65m
- Spotlight Therapeutics, Inc. funding round, October 2020: $16m
Spotlight Therapeutics Series B round, March 2022
$36.5m
Spotlight Therapeutics Funding Round, January 2022
$65m
Spotlight Therapeutics, Inc. funding round, October 2020
$16m
Industries
Spotlight Therapeutics is active in the following industries: